Rikova K (2008) CST Curation Set: 4136; Year: 2008; Biosample/Treatment: tissue, lung/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: RXXp[ST] Antibodies Used to Purify Peptides prior to LCMS: Phospho-Akt Substrate (RXRXXS/T) (110B7) Rabbit mAb Cat#: 9614, PTMScan(R) Phospho-Akt Substrate Motif (RXXS*/T*) Immunoaffinity Beads Cat#: 1978

This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.

Click on the protein name to open the protein page, and on the RSD number to open the site page.

Download

S210-p - AHNAK (human) ▲
Modsite: ktVIRLPsGsGAAsP SwissProt Entrez-Gene Orthologous residues AHNAK (human): S210‑p, AHNAK iso2 (human): ‑, AHNAK (mouse): S211‑p, AHNAK (rat): S211‑p, AHNAK iso2 (rat): S211‑p, AHNAK (cow): S211‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S557-p - ATF7IP (human) ▲
Modsite: EFSRRKRsksEDMDN SwissProt Entrez-Gene Orthologous residues ATF7IP (human): S557‑p, ATF7IP iso2 (human): S556‑p, ATF7IP iso4 (human): S565‑p, ATF7IP (mouse): S591‑p, ATF7IP (rat): S588‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S1504-p - ChaK1 (human) ▲
Modsite: EKIsRRPstEDtHEV SwissProt Entrez-Gene Orthologous residues ChaK1 (human): S1504‑p, ChaK1 (mouse): S1502‑p, ChaK1 (rat): S1501‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S406-p - EIF4B (human) ▲
Modsite: RPRERHPsWRsEEtQ SwissProt Entrez-Gene Orthologous residues EIF4B (human): S406‑p, EIF4B (mouse): S406‑p, EIF4B (rat): S406‑p, EIF4B (cow): S406‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T1179-p - eIF4G (human) ▲
Modsite: DRLDRARtPATKRsF SwissProt Entrez-Gene Orthologous residues eIF4G (human): T1179‑p, eIF4G iso3 (human): T1139‑p, eIF4G iso8 (human): T1180‑p, eIF4G iso9 (human): T1186‑p, eIF4G (mouse): T1181‑p, eIF4G iso2 (mouse): T1167‑p, eIF4G (rat): T1179‑p, eIF4G (rabbit): T982‑p, eIF4G (cow): T1206‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S1185-p - eIF4G (human) ▲
Modsite: RtPATKRsFskEVEE SwissProt Entrez-Gene Orthologous residues eIF4G (human): S1185‑p, eIF4G iso3 (human): S1145‑p, eIF4G iso8 (human): S1186‑p, eIF4G iso9 (human): S1192‑p, eIF4G (mouse): S1187‑p, eIF4G iso2 (mouse): S1173‑p, eIF4G (rat): S1185‑p, eIF4G (rabbit): S988‑p, eIF4G (cow): S1212‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T1139-p - eIF4G iso3 (human) ▲
Modsite: DRLDRARtPATKRsF SwissProt Entrez-Gene Orthologous residues eIF4G (human): T1179‑p, eIF4G iso3 (human): T1139‑p, eIF4G iso8 (human): T1180‑p, eIF4G iso9 (human): T1186‑p, eIF4G (mouse): T1181‑p, eIF4G iso2 (mouse): T1167‑p, eIF4G (rat): T1179‑p, eIF4G (rabbit): T982‑p, eIF4G (cow): T1206‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S1145-p - eIF4G iso3 (human) ▲
Modsite: RtPATKRsFsKEVEE SwissProt Entrez-Gene Orthologous residues eIF4G (human): S1185‑p, eIF4G iso3 (human): S1145‑p, eIF4G iso8 (human): S1186‑p, eIF4G iso9 (human): S1192‑p, eIF4G (mouse): S1187‑p, eIF4G iso2 (mouse): S1173‑p, eIF4G (rat): S1185‑p, eIF4G (rabbit): S988‑p, eIF4G (cow): S1212‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S2152-p - FLNA (human) ▲
Modsite: tRRRRAPsVANVGsH SwissProt Entrez-Gene Orthologous residues FLNA (human): S2152‑p, FLNA iso2 (human): S2144‑p, FLNA (mouse): S2152‑p, FLNA (rat): S2144‑p, FLNA (cow): S2155‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S154-p - GBP1 (human) ▲
Modsite: ELTHRIRsKssPDEN SwissProt Entrez-Gene Orthologous residues GBP1 (human): S154‑p, GBP1 (mouse): S154‑p, GBP1 iso2 (mouse): S154‑p, GBP1 (rat): A156‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S154-p - GBP3 (human) ▲
Modsite: ELTHRIRsKssPDEN SwissProt Entrez-Gene Orthologous residues GBP3 (human): S154‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S784-p - GTF2I (human) ▲
Modsite: GVPFRRPstFGIPRL SwissProt Entrez-Gene Orthologous residues GTF2I (human): S784‑p, GTF2I iso2 (human): S743‑p, GTF2I iso4 (human): S763‑p, GTF2I (mouse): S784‑p, GTF2I iso8 (mouse): S744‑p, GTF2I (rat): S765‑p, GTF2I iso2 (rat): S699‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S743-p - GTF2I iso2 (human) ▲
Modsite: GVPFRRPstFGIPRL SwissProt Entrez-Gene Orthologous residues GTF2I (human): S784‑p, GTF2I iso2 (human): S743‑p, GTF2I iso4 (human): S763‑p, GTF2I (mouse): S784‑p, GTF2I iso8 (mouse): S744‑p, GTF2I (rat): S765‑p, GTF2I iso2 (rat): S699‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S87-p - HN1 (human) ▲
Modsite: sGLQRRNssEAssGD SwissProt Entrez-Gene Orthologous residues HN1 (human): S87‑p, HN1 iso2 (human): S87‑p, HN1 (mouse): S87‑p, HN1 (rat): S82‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S422-p - IRTKS (human) ▲
Modsite: PtPVRsIstVNLSEN SwissProt Entrez-Gene Orthologous residues IRTKS (human): S422‑p, IRTKS (mouse): S421‑p, IRTKS (rat): S423‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S183-p - MAP7D3 (human) ▲
Modsite: SKTANKRsAstEKLE SwissProt Entrez-Gene Orthologous residues MAP7D3 (human): S183‑p, MAP7D3 iso3 (human): ‑, MAP7D3 iso4 (human): S165‑p, MAP7D3 (mouse): ‑ Characterization Methods used to characterize site in vivo:  mass spectrometry

S188-p - matrin 3 (human) ▲
Modsite: kRHFRRDsFDDrGPs SwissProt Entrez-Gene Orthologous residues matrin 3 (human): S188‑p, matrin 3 iso2 (human): ‑, matrin 3 iso3 (human): S188‑p, matrin 3 (mouse): S188‑p, matrin 3 (rat): S188‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S188-p - matrin 3 iso3 (human) ▲
Modsite: KRHFRRDsFDDRGPs SwissProt Entrez-Gene Orthologous residues matrin 3 (human): S188‑p, matrin 3 iso2 (human): ‑, matrin 3 iso3 (human): S188‑p, matrin 3 (mouse): S188‑p, matrin 3 (rat): S188‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S104-p - PEA-15 (human) ▲
Modsite: tkLtRIPsAKKykDI SwissProt Entrez-Gene Orthologous residues PEA‑15 (human): S104‑p, PEA‑15 iso2 (human): S125‑p, PEA‑15 (mouse): S104‑p, PEA‑15 (rat): S104‑p, PEA‑15 (hamster): S104‑p, PEA‑15 (cow): S104‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S116-p - PEA-15 (human) ▲
Modsite: kDIIRQPsEEEIIKL SwissProt Entrez-Gene Orthologous residues PEA‑15 (human): S116‑p, PEA‑15 iso2 (human): S137‑p, PEA‑15 (mouse): S116‑p, PEA‑15 (rat): S116‑p, PEA‑15 (hamster): S116‑p, PEA‑15 (cow): S116‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S4268-p - Plectin-1 (human) ▲

Modsite: KKRERKtssKssVRK SwissProt Entrez-Gene Orthologous residues Plectin‑1 (human): S4268‑p, Plectin‑1 iso2 (human): S4158‑p, Plectin‑1 iso3 (human): S4154‑p, Plectin‑1 iso4 (human): S4131‑p, Plectin‑1 iso5 (human): S4131‑p, Plectin‑1 iso6 (human): S4135‑p, Plectin‑1 iso8 (human): S4109‑p, Plectin‑1 iso9 (human): S4117‑p, Plectin‑1 (mouse): S4275‑p, Plectin‑1 iso3 (mouse): S4127‑p, Plectin‑1 iso6 (mouse): S4156‑p, Plectin‑1 (rat): S4271‑p, Plectin‑1 iso2 (rat): S4128‑p, Plectin‑1 (cow): S4228‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S4158-p - Plectin-1 iso2 (human) ▲

Modsite: KKRERKtssKSsVRK SwissProt Entrez-Gene Orthologous residues Plectin‑1 (human): S4268‑p, Plectin‑1 iso2 (human): S4158‑p, Plectin‑1 iso3 (human): S4154‑p, Plectin‑1 iso4 (human): S4131‑p, Plectin‑1 iso5 (human): S4131‑p, Plectin‑1 iso6 (human): S4135‑p, Plectin‑1 iso8 (human): S4109‑p, Plectin‑1 iso9 (human): S4117‑p, Plectin‑1 (mouse): S4275‑p, Plectin‑1 iso3 (mouse): S4127‑p, Plectin‑1 iso6 (mouse): S4156‑p, Plectin‑1 (rat): S4271‑p, Plectin‑1 iso2 (rat): S4128‑p, Plectin‑1 (cow): S4228‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S4131-p - Plectin-1 iso4 (human) ▲

Modsite: KKRERKtssKSsVRK SwissProt Entrez-Gene Orthologous residues Plectin‑1 (human): S4268‑p, Plectin‑1 iso2 (human): S4158‑p, Plectin‑1 iso3 (human): S4154‑p, Plectin‑1 iso4 (human): S4131‑p, Plectin‑1 iso5 (human): S4131‑p, Plectin‑1 iso6 (human): S4135‑p, Plectin‑1 iso8 (human): S4109‑p, Plectin‑1 iso9 (human): S4117‑p, Plectin‑1 (mouse): S4275‑p, Plectin‑1 iso3 (mouse): S4127‑p, Plectin‑1 iso6 (mouse): S4156‑p, Plectin‑1 (rat): S4271‑p, Plectin‑1 iso2 (rat): S4128‑p, Plectin‑1 (cow): S4228‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S4135-p - Plectin-1 iso6 (human) ▲

Modsite: KKRERKtssKSsVRK SwissProt Entrez-Gene Orthologous residues Plectin‑1 (human): S4268‑p, Plectin‑1 iso2 (human): S4158‑p, Plectin‑1 iso3 (human): S4154‑p, Plectin‑1 iso4 (human): S4131‑p, Plectin‑1 iso5 (human): S4131‑p, Plectin‑1 iso6 (human): S4135‑p, Plectin‑1 iso8 (human): S4109‑p, Plectin‑1 iso9 (human): S4117‑p, Plectin‑1 (mouse): S4275‑p, Plectin‑1 iso3 (mouse): S4127‑p, Plectin‑1 iso6 (mouse): S4156‑p, Plectin‑1 (rat): S4271‑p, Plectin‑1 iso2 (rat): S4128‑p, Plectin‑1 (cow): S4228‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S4117-p - Plectin-1 iso9 (human) ▲

Modsite: KKRERKtssKSSVRK SwissProt Entrez-Gene Orthologous residues Plectin‑1 (human): S4268‑p, Plectin‑1 iso2 (human): S4158‑p, Plectin‑1 iso3 (human): S4154‑p, Plectin‑1 iso4 (human): S4131‑p, Plectin‑1 iso5 (human): S4131‑p, Plectin‑1 iso6 (human): S4135‑p, Plectin‑1 iso8 (human): S4109‑p, Plectin‑1 iso9 (human): S4117‑p, Plectin‑1 (mouse): S4275‑p, Plectin‑1 iso3 (mouse): S4127‑p, Plectin‑1 iso6 (mouse): S4156‑p, Plectin‑1 (rat): S4271‑p, Plectin‑1 iso2 (rat): S4128‑p, Plectin‑1 (cow): S4228‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S29-p - RALBP1 (human) ▲
Modsite: sGLtRtPssEEIsPt SwissProt Entrez-Gene Orthologous residues RALBP1 (human): S29‑p, RALBP1 (mouse): S29‑p, RALBP1 (rat): S29‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S89-p - RDBP (human) ▲
Modsite: KNSGFKRsRtLEGkL SwissProt Entrez-Gene Orthologous residues RDBP (human): S89‑p, RDBP iso3 (human): S96‑p, RDBP (mouse): S89‑p, RDBP (rat): S89‑p, RDBP (cow): S89‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T91-p - RDBP (human) ▲
Modsite: SGFKRsRtLEGkLKD SwissProt Entrez-Gene Orthologous residues RDBP (human): T91‑p, RDBP iso3 (human): T98‑p, RDBP (mouse): T91‑p, RDBP (rat): T91‑p, RDBP (cow): T91‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S273-p - REPS1 (human) ▲
Modsite: IEIRRQsssyDDPWK SwissProt Entrez-Gene Orthologous residues REPS1 (human): S273‑p, REPS1 iso2 (human): S273‑p, REPS1 iso3 (human): S273‑p, REPS1 iso4 (human): S273‑p, REPS1 (mouse): S273‑p, REPS1 iso3 (mouse): S221‑p, REPS1 (rat): S273‑p, REPS1 iso4 (rat): ‑ Characterization Methods used to characterize site in vivo:  mass spectrometry

S235-p - S6 (human) ▲
Modsite: IAKRRRLssLRAsts SwissProt Entrez-Gene Orthologous residues S6 (human): S235‑p, S6 (mouse): S235‑p, S6 (rat): S235‑p, S6 (fruit fly): A234‑p, S6 (cow): S235‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S236-p - S6 (human) ▲
Modsite: AKRRRLssLRAstsK SwissProt Entrez-Gene Orthologous residues S6 (human): S236‑p, S6 (mouse): S236‑p, S6 (rat): S236‑p, S6 (fruit fly): S235‑p, S6 (cow): S236‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S319-p - SCAMP2 (human) ▲
Modsite: RTFHRAAssAAQGAF SwissProt Entrez-Gene Orthologous residues SCAMP2 (human): S319‑p, SCAMP2 (mouse): S319‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S307-p - SGTA (human) ▲
Modsite: RsRtPsAsNDDQQE_ SwissProt Entrez-Gene Orthologous residues SGTA (human): S307‑p, SGTA (mouse): S309‑p, SGTA (rat): S308‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S146-p - SLY (human) ▲
Modsite: PVLsRQAstGsELCs SwissProt Entrez-Gene Orthologous residues SLY (human): S146‑p, SLY (mouse): S146‑p, SLY (rat): S146‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S43-p - TBC1D5 (human) ▲
Modsite: NKNGRRtsstLDsEG SwissProt Entrez-Gene Orthologous residues TBC1D5 (human): S43‑p, TBC1D5 iso2 (human): S43‑p, TBC1D5 (mouse): N43‑p, TBC1D5 (rat): N43‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

S899-p - tensin 1 (human) ▲
Modsite: PLRRRAAsDGQyENQ SwissProt Entrez-Gene Orthologous residues tensin 1 (human): S899‑p, tensin 1 iso2 (human): ‑, tensin 1 (mouse): S1054‑p, tensin 1 (rat): S1073‑p, tensin 1 (cow): S902‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T48-p - VAMP8 (human) ▲
Modsite: LEHLRNktEDLEAts SwissProt Entrez-Gene Orthologous residues VAMP8 (human): T48‑p, VAMP8 (mouse): T48‑p, VAMP8 (rat): T47‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

T1462-p - ZZEF1 (human) ▲
Modsite: PLNkRQRtssVVEEH SwissProt Entrez-Gene Orthologous residues ZZEF1 (human): T1462‑p, ZZEF1 iso3 (human): ‑, ZZEF1 (mouse): T1462‑p, ZZEF1 (rat): T1461‑p Characterization Methods used to characterize site in vivo:  mass spectrometry